Opened at ₹28.32 on NSE (-11.50%) and ₹28.30 on BSE (-11.56%) against the ₹32 issue price, fell as far as ₹23.40 intraday (-26.87%) and closed its first session at ₹26.10 on BSE (-18.44%). Closed subscribed around 5x (NII 8.53x, retail 4.82x, QIB 3.42x).
What about GMP?
We don't track or publish a Grey Market Premium figure for AceVector (Snapdeal) — GMP is an unofficial, unregulated number that moves by the hour and is often wrong close to listing day. What's above instead is sourced directly from NSE/BSE filings and the issue's own prospectus, and we say plainly when a number is just a snapshot rather than live.
How to research this IPO
A checklist, not a verdict generator — work through these before forming your own view on AceVector (Snapdeal).
What does the company actually do?
Get past the tagline — what specifically generates its revenue, and for whom?
How does it make money?
One dominant revenue line, or several? Which is growing, which is shrinking?
What does its financial history actually show?
Revenue and profit trend over 3+ years, not just the most recent flattering quarter.
What's happening in its industry right now?
Growing, mature, or under pressure — and is this IPO timed to ride a trend?
How does it compare to its listed peers?
Same growth rate, margins, and debt load — or is it being priced like a peer it doesn't actually resemble?
Is the asking valuation reasonable?
Compare its P/E, P/B, or EV/EBITDA at the IPO price band against listed peers — see our valuation primer.
What are the genuine strengths?
Market position, brand, distribution, technology — specific advantages, not marketing language.
What are the disclosed risks?
The prospectus's own "Risk Factors" section is required reading — it's where companies must legally disclose what could go wrong.
What would you still need to know?
Write down your open questions before applying — a genuine gap in your own understanding is a reason to wait, not to guess.
Issue size, price band, dates, and subscription figures for AceVector (Snapdeal) are sourced from public reporting at the time this page was last updated and are not live — always confirm current details on the exchange (NSE/BSE) or the issue's official RHP/prospectus before applying. Nothing on this page is investment advice or a recommendation to apply for, buy, sell, or hold any security. Always do your own research or consult a registered investment adviser before making financial decisions. See the full IPO tracker for every issue we're currently covering.